TKa biomarker | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

14,082 results for “TKa biomarker”

Trials

View all 10694 →

DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

100 participants · First posted Apr 29, 2024

Tka Assay for CDK4/6i

34 participants · First posted Aug 27, 2024

ARVIS TKA vs Conventional TKA

50 participants · First posted Oct 29, 2024

Drugs

View all 386 →

TKA-731

TKA-457

Indolepropionic acid

C₁₁H₁₁NO₂

Organizations

View all 20 →

Stemina Biomarker Discovery, Inc

United States

FRED HUTCHINSON CANCER CENTER

United States

Compugen

News

View all 2982 →

Biovica Secures Commercial Agreement with Leading NCI Cancer Center for DiviTum TKa Biomarker Test

Biovica Expands Oncology Partnership with US Biotech Firm in SEK 2.5M TKa Testing Deal

Biovica Partners with Tempus to Expand Access to DiviTum TKa Blood Test for Metastatic Breast Cancer Monitoring

Page 1 of 1409